GKV Capital Management Co. Inc. Invests $232,000 in CME Group Inc. (NASDAQ:CME)

GKV Capital Management Co. Inc. acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the 1st quarter, Holdings Channel reports. The fund acquired 875 shares of the financial services provider’s stock, valued at approximately $232,000.

Several other large investors have also recently modified their holdings of the stock. Bank Pictet & Cie Europe AG boosted its holdings in CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider’s stock valued at $20,190,000 after acquiring an additional 19,533 shares during the period. Advisory Services Network LLC lifted its holdings in shares of CME Group by 15.5% in the 4th quarter. Advisory Services Network LLC now owns 1,609 shares of the financial services provider’s stock worth $374,000 after buying an additional 216 shares during the period. Mariner LLC raised its position in shares of CME Group by 4.3% in the 4th quarter. Mariner LLC now owns 98,052 shares of the financial services provider’s stock worth $22,770,000 after acquiring an additional 4,024 shares in the last quarter. CreativeOne Wealth LLC raised its position in shares of CME Group by 24.1% in the 4th quarter. CreativeOne Wealth LLC now owns 10,410 shares of the financial services provider’s stock worth $2,417,000 after acquiring an additional 2,021 shares in the last quarter. Finally, Aware Super Pty Ltd as trustee of Aware Super bought a new position in shares of CME Group in the 4th quarter worth $2,086,000. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $275.88 on Wednesday. The stock has a market capitalization of $99.42 billion, a price-to-earnings ratio of 26.71, a PEG ratio of 5.07 and a beta of 0.44. CME Group Inc. has a one year low of $204.16 and a one year high of $290.79. The company’s 50-day simple moving average is $275.61 and its 200-day simple moving average is $266.55. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business earned $2.56 earnings per share. CME Group’s revenue was up 10.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Keefe, Bruyette & Woods upped their target price on CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a research report on Thursday, April 24th. Piper Sandler upped their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Erste Group Bank downgraded CME Group from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 24th. UBS Group reiterated a “neutral” rating and set a $305.00 price target on shares of CME Group in a research report on Thursday, July 24th. Finally, Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $261.93.

Insider Activity at CME Group

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the firm’s stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares in the company, valued at $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Phyllis M. Lockett sold 1,060 shares of the business’s stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director directly owned 3,108 shares of the company’s stock, valued at approximately $863,651.04. This represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,750 shares of company stock worth $1,576,294. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.